We classify global small and mid cap (SMID) companies as those with a market capitalisation from USD $1 billion to USD $28 billion. They are vastly larger than the types of companies considered SMID in Australia. This approach to global SMID ensures an investible universe of diversified, liquid and highly profitable stocks. Some of the most interesting companies with the strongest franchises are found in the global SMID sector and include luxury car brand Ferrari; PoolCorp, the largest wholesale distributor of swimming pool supplies in the world; US beauty store chain Ulta Beauty; and Moncler, which sells down jackets and other clothes.
There are many differences when it comes to the Australian versus global SMID market. For instance, size is one of the advantages of the global universe versus its Australian counterpart. The global cohort is much larger, more liquid and companies tend to be of a higher quality.
Additionally, it’s much easier to find companies with the potential to generate value among overseas businesses. Because of the larger universe of opportunities, allocating large amounts of capital to global SMID is also more straightforward than allocating funds to Australian small caps.
Another reason to consider global SMID is because global equities portfolios have changed in recent years. In the world of global equities, it’s no secret that large cap growth stocks, especially those with an emphasis on growth such as giant tech stocks, have accounted for much of the recent gains in equities. As such, many portfolios have become even more heavily skewed towards the larger cap end of the market. This is opening up opportunities to invest in the global SMID space as investors look to diversify away from large and mega caps and gain exposure to a significant part of the global equity market that can provide growth.
At a time when valuations in global large cap stocks and are hitting new highs – the global SMID asset class looks increasingly attractive. When compared to the Australian small cap market (the S&P/ASX Small Ordinaries Index), the global SMID cap index is actually less expensive – the MSCI World SMID Cap Index P/E at 18.6 vs the S&P/ASX Small Ordinaries Index P/E at 19.7x vs its five year average of 16.4.
Furthermore, the global SMID universe simply has not participated in the valuation expansion that has been so prevalent with large cap global growth and IT names. The MSCI World Global SMID Cap Index is now trading at its lowest P/E premium to the MSCI World Index in 10 years (+7.8% vs +15.6% 10 year average), which is in stark contrast to the global IT sector which trades at a 33% premium to the rest of the market.
Absolute and relative P/E of the MSCI World SMID Index over 10 years
An allocation to global SMID also offers a much better value proposition than mega cap names that have driven markets in recent years i.e. Apple, Microsoft, Amazon, Facebook and Alphabet. The valuation risk in these names has arguably grown quite a bit recently as their average P/E now sits at 29x and their average P/E premium to the market sits at 89%.
Having recently visited more than 60 small and mid-cap companies across the US and Europe, three themes emerged that investors can take into account when making decisions about allocating funds to small and medium cap companies.
The strength of the American labour market is the first. In 2019, more than 2.1 million extra people gained employment in the US. As the market tightens, a lack of skilled labour and labour availability is emerging as a challenge for US businesses. This bodes well for the US economy this year and the small to medium-cap companies in it.
Chinese growth is the second theme to watch. According to official Chinese data, economic growth is running at 6%. But anecdotal evidence suggests this figure could be much lower. This is a risk to watch in 2020, one that could have flow on effects to European economies in particular.
The recent development of the coronavirus in China represents yet another challenge for their economy. While the bulk of the near term pain will clearly be felt domestically – the ramifications for global businesses with meaningful China exposure are quickly becoming apparent. Some of the larger global players in the luxury, restaurant, travel and tech industries have already flagged that earnings will be impacted by the coronavirus.
From an asset allocation perspective – the coronavirus has highlighted the inherent risks in two of the best known ‘growth sleeves’ in global equities – large cap growth (valuation risk), and emerging markets (macro and earnings risk). In doing so, it also highlights two of the most compelling attributes of the global SMID asset class – they come with meaningfully less valuation risk, and as companies domiciled in developed markets – they tend to be more domestically focused.
A related theme is the US/China trade war and global capex spending, which has been on hold since February 2019. Investors have been looking for some pent up demand in capex spending to stimulate economic growth, especially in Europe. But Bell Asset Management’s research suggests this is not yet happening. Capex plans are still on pause, although this may change as the US and China have recently come to some resolutions around the trade war.
Markets have recovered since reaching a nadir in January 2019. While there are concerns about how much further they could rise, our view is they still have some way to run. Brexit’s resolution, which could prompt an uptick in economic growth, is one reason for this. The US job market’s strength is another signal markets could outperform in 2020.
Time will tell how these themes play out and how they will impact global small and mid-cap companies.
For more information, visit Bell Asset Management.
Get our latest updates and investment manager performance reports